Design Therapeutics, Inc. DSGN Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Design Therapeutics, Inc. (DSGN) reported operating lease right-of-use assets in other assets of $2.57M in Q1 2026.
- How has Design Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Design Therapeutics, Inc.'s operating lease right-of-use assets in other assets increased by 26.7% year-over-year, from $2.03M to $2.57M.
- What is the long-term trend for Design Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a -20.6% compound annual growth rate (CAGR), from $3.61M to $1.44M.